As of March 2026 Neuphoria Therapeutics has a market cap of A$32.25 Million. This makes Neuphoria Therapeutics the world's 10062th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Mar 2nd, 2026 the market cap of Neuphoria Therapeutics was reported to be: